Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade-Reference-Cited by-同舟云学术

Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade

Published:2015-08-27 Issue:8 Volume:10 Page:e0135645
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Do Albert,Mittal Yash,Liapakis AnnMarie,Cohen Elizabeth,Chau Hong,Bertuccio Claudia,Sapir Dana,Wright Jessica,Eggers Carol,Drozd Kristine,Ciarleglio Maria,Deng Yanhong,Lim Joseph K.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. Sofosbuvir: A Nucleotide NS5B Inhibitor for the Treatment of Chronic Hepatitis C Infection;L Rose;Ann Pharmacother,2014

2. Advances in newly developing therapy for chronic hepatitis C virus infection;PJ Pockros;Front Med,2014

3. AASLD/IDSA/IAS–USA. Recommendations for testing, managing, and treating hepatitis C [updated December 19, 2014]. Available: http://www.hcvguidelines.org/.

4. HCV direct-acting antiviral agents: the best interferon-free combinations;R Schinazi;Liver Int,2014

5. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;N Afdhal;N Engl J Med,2014

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: cirrhosis is the growing burden of hepatitis C virus-related disease;European Journal of Cancer Prevention;2024-03-22

2. Hepatitis C virus care cascade among people who inject drugs in Puerto Rico: Minimal HCV treatment and substantial barriers to HCV care;Drug and Alcohol Dependence Reports;2023-09

3. Global treatment rate and barriers to direct‐acting antiviral therapy: A systematic review and meta‐analysis of 146 studies and 1 760 352 hepatitis C virus patients;Liver International;2023-03-08

4. How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States;International Journal of Drug Policy;2023-02

5. Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial;Open Forum Infectious Diseases;2022-05-07